Brett P. Monia ā Founder, COO and Senior VP of Drug Discovery & Corporate Development at Ionis Pharmaceuticals
Executive Bio
Dr. Brett P. Monia, Ph.D., is a Founder of Ionis Pharmaceuticals, Inc. and has been its Senior Vice President of Drug Discovery & Corporate Development since January 2012 and its Chief Operating Officer since January 15, 2018. Dr. Monia served as Senior Vice President of Antisense Drug Discovery at Ionis Pharmaceuticals (Isis Pharmaceuticals, Inc.) since January 2012. Dr. Monia is a founding member of Isis and Senior Vice President of Antisense Drug Discovery. Dr. Monia is also the Franchise Leader for Programs in Oncology and Rare Genetic Diseases at Isis Pharmaceuticals. He is responsible for establishing strategic directions for preclinical drug discovery research focused on RNA-directed therapeutic platforms, establishment and supervision of early clinical development strategies through clinical proof-of-concept and coordinating research activities with clinical investigators, consultants and with corporate partners. His contributions include research into the medicinal chemistry and mechanisms of action of oligonucleotide-based drugs in cell culture and in animals and in the establishment of numerous preclinical and clinical programs in various therapeutic areas, including oncology, metabolic disease, inflammation, cardiovascular disease and rare diseases. Programs under Dr. Monia's direct supervision have resulted in the clinical development of more than twenty antisense-based drugs to date, covering areas as diverse as cancer, type 2 diabetes, cardiovascular disease, asthma and rare genetic diseases. Dr. Monia's publication record exceeds 150 primary research manuscripts, reviews and book chapters and is an inventor on more than 100 issued patents. In addition, Dr. Monia serves on the editorial boards for a number of scientific journals, is a member of the American Association of Cancer Research, the American Diabetes Association, the American Association for the Study of Liver Diseases, the American Society of Hematology and serves on the Board of Directors for the Oligonucleotide Therapeutics Society. He also holds a position as a scientific advisory board member with OncoGeneX Technologies, Inc., and is an adjunct professor of biology at San Diego State University where he lectures at the graduate level on pharmacology. Mr. Monia received his Ph.D. in Pharmacology at the University of Pennsylvania and B.S. degrees in Molecular Biology and Analytical Chemistry at Stockton State College, in Pomona, New Jersey.
Founder, COO and Senior VP of Drug Discovery & Corporate Development Impact on Operations Department's Culture
Brett P. Monia holds the highest position within the Operations department at Ionis Pharmaceuticals ā Founder, COO and Senior VP of Drug Discovery & Corporate Development, and therefore has influence on the culture of the Operations department.
Are you challenged at work?
Are your company's goals clear, and are you invested in them?
Are you satisfied with your work/life balance?
Is your work environment positive or negative?
How would you rate the value & quality of meetings at your company?
Does your current company provide you meaningful opportunities for career advancement?
Executive Team Culture Ratings from Ionis Pharmaceuticals Employees
BOTTOM
15%
Ionis Pharmaceuticals' Executive Team scores in the Bottom 15%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Ionis PharmaceuticalsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Ionis PharmaceuticalsIonis Pharmaceuticals' Executive Team at a Glance
Based on 14 ratings, Ionis Pharmaceuticals' employees are less satisfied with their Executive Team and give them a āDā or 53/100.
Ionis Pharmaceuticals' Executive Team ranks in the Bottom 20% of other companies in San Diego and Bottom 15% of other companies on Comparably that also have 201-500 Employees.
×